QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
NASDAQ:NH

NantHealth - NH Stock Forecast, Price & News

$3.59
+0.13 (+3.76%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$3.45
$3.59
50-Day Range
$0.19
$5.70
52-Week Range
$1.57
$15.75
Volume
1,873 shs
Average Volume
24,586 shs
Market Capitalization
$27.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NantHealth MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
2.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
0.32mentions of NantHealth in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Medical Sector

647th out of 1,027 stocks

Data Processing & Preparation Industry

46th out of 70 stocks

NH stock logo

About NantHealth (NASDAQ:NH) Stock

NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Morrisville, NC.

Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Stock News Headlines

StockNews.com Begins Coverage on NantHealth (NASDAQ:NH)
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
NantHealth Announces 1-for-15 Reverse Stock Split
NantHealth Reports 2022 Third Quarter Financial Results
New "Vertical" Technology Solves Solar Power's Major Flaw
Even conservationists hate conventional solar farms. That's because they take up too much land and can degrade the environment. And let's face it, land is expensive...Fortunately, new groundbreaking tower technology solves solar's #1 drawback. These unique vertical structures not only take up to 90% less land space, but also generate extra electric power.
NantHealth, Inc. (NASDAQ: NH)
NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript
See More Headlines
Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Company Calendar

Last Earnings
11/04/2021
Today
2/06/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
326
Year Founded
N/A

Profitability

Net Income
$-58,260,000.00
Pretax Margin
-89.67%

Debt

Sales & Book Value

Annual Sales
$62.65 million
Book Value
($21.04) per share

Miscellaneous

Free Float
2,983,000
Market Cap
$27.68 million
Optionable
Optionable
Beta
1.88

Key Executives

  • Patrick Soon-ShiongPatrick Soon-Shiong
    Chairman & Chief Executive Officer
  • Ronald Allen LouksRonald Allen Louks
    Chief Operating Officer
  • Bob Petrou
    Chief Financial Officer
  • Tiffany Avery
    Chief Medical Officer
  • Brandon Villery
    Secretary, Senior VP-Legal, VP & General Counsel













NH Stock - Frequently Asked Questions

How have NH shares performed in 2023?

NantHealth's stock was trading at $3.65 at the beginning of the year. Since then, NH stock has decreased by 1.6% and is now trading at $3.59.
View the best growth stocks for 2023 here
.

Are investors shorting NantHealth?

NantHealth saw a decrease in short interest in January. As of January 15th, there was short interest totaling 56,200 shares, a decrease of 29.1% from the December 31st total of 79,300 shares. Based on an average trading volume of 100,500 shares, the short-interest ratio is presently 0.6 days. Approximately 2.2% of the shares of the company are short sold.
View NantHealth's Short Interest
.

When is NantHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our NH earnings forecast
.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) posted its quarterly earnings data on Thursday, November, 4th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The company earned $14.36 million during the quarter, compared to the consensus estimate of $17.70 million. During the same period last year, the business posted ($0.08) EPS.

What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?

82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

When did NantHealth IPO?

(NH) raised $91 million in an IPO on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

Who are NantHealth's major shareholders?

NantHealth's stock is owned by many different retail and institutional investors. Top institutional shareholders include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Patrick Soon-Shiong and Ronald Allen Louks.
View institutional ownership trends
.

How do I buy shares of NantHealth?

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $3.59.

How much money does NantHealth make?

NantHealth (NASDAQ:NH) has a market capitalization of $27.68 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($7.6462) on an earnings per share basis.

How many employees does NantHealth have?

The company employs 326 workers across the globe.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com.

This page (NASDAQ:NH) was last updated on 2/6/2023 by MarketBeat.com Staff